The vaccine is currently authorized for use in children only over 12 years of age in both the United States and the European Union
Pfizer earlier this month asked to grant emergency use authorization of the shot for young children
an advisory panel to the Food and Drug Administration (FDA) is expected to meet next month to review the data
children are less susceptible to severe COVID-19, they can spread the virus to others
Pfizer/BioNTech vaccine has been shown to induce a strong immune response in 5 to 11 year olds in a 2,268-participant clinical trial, the companies said on Sept.
an advisory panel to the Food and Drug Administration (FDA) is expected to meet next month to review the data
children are less susceptible to severe COVID-19, they can spread the virus to others
Pfizer/BioNTech vaccine has been shown to induce a strong immune response in 5 to 11 year olds in a 2,268-participant clinical trial, the companies said on Sept.